Revenue Cycle Management (RCM) Analytics as a Service (AaaS) Solution
ATLANTA (August 2020) – JTS Health Partners (JTS) recently announced the release of a new Revenue Cycle Management (RCM) Analytics as a Service (AaaS) solution, nCREAS™
. JTS’ patent pending solution offers analytics for accounts receivable (A/R), productivity and cash management, denials management, and health information management (HIM), including targeted Diagnosis-Related Groups (DRG), COVID-19, and complication or comorbidity/major complication or comorbidity (CC/MCC) capture rates.
nCREAS™ offers powerful, predictive tools to enhance efficiencies and processes for optimum financial and operational performance for hospitals and physician practices. Using near real time data, nCREAS™ establishes predictive measurements of future revenue. Multiple data sources, combined into a usable information stream, allow accurate comprehension of both positive and problematic trends. In addition, nCREAS™ pinpoints areas requiring process improvement.
nCREAS™, previously utilized exclusively for the HIM portion of the JTS analytics offering, is now an all-encompassing RCM AaaS solution for client financial success.
“JTS is excited to offer nCREAS™, our RCM Analytics as a Service offering, to assist our clients with optimizing revenue capture, A/R and cash management. Accurate revenue capture is always key to an organization’s success, but even more so during these unique times in which we are currently facing,” says Thomas Stewart, President, CEO, and Co-Founder of JTS.
For more information on how nCREAS™ can assist healthcare organizations, contact JTS Health Partners at (470) 443-3507 or jtshealthpartners.com. JTS Health Partners is a specialized, national healthcare professional services firm. Our portfolio and expertise concentrate highly skilled professionals within revenue cycle management, health information management, information technology, and analytics services focused on hospital and physician clients.
© 2020 JTS Ventures, Inc., d/b/a JTS Health Partners (“JTS”), a United States entity. All rights reserved. The information contained herein is intended for general guidance only. No one should act upon such information without appropriate professional advice. JTS shall not be responsible for any loss whatsoever sustained by any organization or person who relies on this publication. The nCREAS™ AaaS is currently patent pending.